Obviating the antihistaminic sedative factor with a new antiallergic.
D018926:Anti-Allergic Agents; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010880:Piperidines / Q000008:administration & dosage*; D014309:Tripelennamine / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010880:Piperidines; D014309:Tripelennamine
ANALEPTICS/therapeutic use; ANTIHISTAMINICS; PIPERIDINES/administration; TRIPELENNAMINE/therapeutic use